Non‑alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism

Thumbnail Image

Files

s00535-023-02075-7.pdf (1.4 MB)

Identifiers

URI: https://hdl.handle.net/10630/29349
DOI: 10.1007/s00535-023-02075-7

Publication date

2024-01-24

Reading date

Authors

Collaborators

Advisors

Tutors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Metrics

Google Scholar

Share

Export

Research Projects

Organizational Units

Journal Issue

Center

Facultad de Medicina

Department/Institute

IBIMA. Instituto de Investigación Biomédica de Málaga

Keywords

Hígado - Enfermedades
Metabolismo - Alteraciones
Obesidad
Hepatitis

Abstract

Alterations in gut microbiota are associated with the pathogenesis of metabolic diseases, including metabolic-associated fatty liver disease (MAFLD). The aim of this study was to evaluate gut microbiota composition and functionality in patients with morbid obesity with different degrees of MAFLD, as assessed by biopsy.

Description

Bibliographic citation

Cornejo-Pareja, I., Amiar, M.R., Ocaña-Wilhelmi, L. et al. Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism. J Gastroenterol (2024). https://doi.org/10.1007/s00535-023-02075-7

Collections

Artículos

Endorsement

Review

Supplemented By

Referenced by

Creative Commons license

Atribución 4.0 Internacional
Except where otherwised noted, this item's license is described as Atribución 4.0 Internacional